Carta al Editor
Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment
Read
1134
Timeswas read the article
24
Total PDF
1102
Total HTML
8
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 January | 22 | 0 | 0 | 22 |
| 2022 December | 41 | 2 | 1 | 44 |
| 2022 November | 41 | 0 | 0 | 41 |
| 2022 October | 40 | 4 | 2 | 46 |
| 2022 September | 49 | 2 | 1 | 52 |
| 2022 August | 41 | 0 | 0 | 41 |
| 2022 July | 58 | 6 | 2 | 66 |
| 2022 June | 78 | 2 | 1 | 81 |
| 2022 May | 169 | 2 | 0 | 171 |
| 2022 April | 334 | 2 | 1 | 337 |
| 2022 March | 229 | 4 | 0 | 233 |
